These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6765400)

  • 41. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides.
    Torzewska A; Stączek P; Róźalski A
    J Med Microbiol; 2003 Jun; 52(Pt 6):471-477. PubMed ID: 12748265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract.
    Senior BW; Loomes LM; Kerr MA
    J Med Microbiol; 1991 Oct; 35(4):203-7. PubMed ID: 1941989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteus mirabilis strains of diverse type have IgA protease activity.
    Senior BW; Albrechtsen M; Kerr MA
    J Med Microbiol; 1987 Sep; 24(2):175-80. PubMed ID: 3309325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Diabetic Patient with Prolonged Hyperammonemia Due to Urinary Tract Infection Caused by Urease-producing Bacteria.
    Inoue S; Yasuda H; Yoshida K; Mori K; Ogawa K; Yokotsuka Y; Okamoto H
    Intern Med; 2024 Jul; 63(13):1945-1949. PubMed ID: 37926530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.
    Millner OE; Andersen JA; Appler ME; Benjamin CE; Edwards JG; Humphrey DT; Shearer EM
    J Urol; 1982 Feb; 127(2):346-50. PubMed ID: 7038144
    [No Abstract]   [Full Text] [Related]  

  • 48. Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection.
    Alteri CJ; Himpsl SD; Mobley HL
    PLoS Pathog; 2015 Jan; 11(1):e1004601. PubMed ID: 25568946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of three techniques for the diagnosis of urinary tract infections in dogs with urolithiasis.
    Gatoria IS; Saini NS; Rai TS; Dwivedi PN
    J Small Anim Pract; 2006 Dec; 47(12):727-32. PubMed ID: 17201824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of purple urine bag syndrome (PUBS).
    Röggla G; Kapiotis S; Fahrner A
    Wien Klin Wochenschr; 2002 May; 114(8-9):306. PubMed ID: 12212364
    [No Abstract]   [Full Text] [Related]  

  • 52. Microbial resistance to antibiotics used to treat urinary tract infections in Mexican children.
    Hernández-Porras M; Salmerón-Arteaga G; Medina-Santillán R
    Proc West Pharmacol Soc; 2004; 47():120-1. PubMed ID: 15633630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
    Alamuri P; Mobley HL
    Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY; Ng SY; Teo L; Koh Y; Teok CH
    J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro.
    Imani Rad H; Peeri H; Amani M; Mohammadnia A; Ogunniyi AD; Khazandi M; Venter H; Arzanlou M
    Microb Pathog; 2019 Jul; 132():293-301. PubMed ID: 31082531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of Escherichia coli strains causing urinary tract infections in patients with transposed intestinal segments.
    Keegan SJ; Graham C; Neal DE; Blum-Oehler G; N'Dow J; Pearson JP; Gally DL
    J Urol; 2003 Jun; 169(6):2382-7. PubMed ID: 12771802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of acetohydroxamic acid on experimental proteus pyelonephritis.
    Maclaren DM
    Invest Urol; 1974 Sep; 12(2):146-9. PubMed ID: 4605277
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of organic mercurials and sulfhydryl compounds on the urease activity of Proteus: inhibition by urine and ascorbic acid.
    Kunin CM
    Antimicrob Agents Chemother; 1976 Sep; 10(3):503-6. PubMed ID: 10828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.